Drug Trial Radar · NCT03473301
A Study of UCB and MSCs in Children With CP: ACCeNT-CP
Last checked: Nov 20, 2026Latest source record: Aug 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
91
Actual
Start
Apr 10, 2018
Primary completion
Feb 26, 2020
Study completion May 31, 2021
Sponsor
- Lead sponsor
- Joanne Kurtzberg, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Marcus Foundation
- First posted
- Mar 22, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 24 months, up to 60 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to estimate change in motor function 12 months after treatment with a single dose of allogeneic umbilical cord blood (AlloCB) or repeated doses of umbilical cord tissue-derived mesenchymal stromal cells (hCT-MSC) in children with cerebral palsy. In addition, this study will contribute much needed data to the clinical trials community on the natural history of the motor function in CP over short-term (less than 1 year) time periods relevant to the conduct of clinical trials and assess the safety of AlloCB and hCT-MSC infusion in children with cerebral palsy.
Conditions
- Cerebral Palsy
Interventions
Infusion of allogeneic umbilical cord bloodBiological
Subjects will receive a single infusion of allogeneic umbilical cord blood at the baseline visit.
Infusion of MSCsBiological
Subjects will receive 3 infusions of MSCs (baseline, 3 months and 6 months).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Gross Motor Function Measure (GMFM-66) in Excess of Expected ChangeTime frame: Baseline to 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Duke University Medical Center
Durham, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.